Cytochrome P450 2D6 as a model antigen.
Cytochrome P450 2D6 (CYP2D6) has been identified as the major autoantigen in type 2 autoimmune hepatitis (AIH). However, because of a lack of appropriate animal models, the etiology of AIH is still poorly understood. We generated a mouse model for AIH using the human CYP2D6 as a triggering molecule for autoimmunity. We infected wild-type FVB mice with an adenovirus expressing human CYP2D6 (Ad-2D6) to break self-tolerance to the mouse CYP2D6 homologues. Ad-2D6-infected mice showed persistent features of liver damage including hepatic fibrosis, cellular infiltrations, focal-to-confluent necrosis and generation of anti-CYP2D6 antibodies, which predominantly recognized the identical immunodominant epitope recognized by LKM-1 antibodies from AIH patients. Interestingly, Ad-2D6 infection of transgenic mice expressing the human CYP2D6 (CYP2D6 mice) resulted in delayed kinetics and reduced severity of liver damage. However, the quantity and quality of anti-CYP2D6 antibodies was only moderately reduced in CYP2D6 mice. In contrast, the frequency of CYP2D6-specific CD4 and CD8 T cells was dramatically decreased in CYP2D6 mice, indicating the presence of a strong T cell tolerance to human CYP2D6 established in CYP2D6 mice, but not in wild-type mice. CYP2D6-specific T cells reacted to human CYP2D6 peptides with intermediate homology to the mouse homologues, but not to those with high homology, indicating that molecular mimicry rather than molecular identity breaks tolerance and subsequently causes severe persistent autoimmune liver damage. The CYP2D6 model provides a platform to investigate mechanisms involved in the immunopathogenesis of autoimmune-mediated chronic hepatic injury and evaluate possible ways of therapeutic interference.
Christen
Urs
U
Klinikum der Goethe-Universität Frankfurt am Main, Pharmazentrum/ZAFES, Frankfurt am Main, Germany. christen@med.uni-frankfurt.de
Holdener
Martin
M
Hintermann
Edith
E
D000256:Adenoviridae; D000818:Animals; D000917:Antibody Formation; D000941:Antigens / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D019389:Cytochrome P-450 CYP2D6 / Q000276:immunology*; D004195:Disease Models, Animal; D005822:Genetic Vectors; D019693:Hepatitis, Autoimmune / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007108:Immune Tolerance; D008099:Liver / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D018716:Molecular Mimicry
D000941:Antigens; D001324:Autoantigens; D019389:Cytochrome P-450 CYP2D6
Nat Med. 2003 Jul;9(7):914-20
12819778
J Autoimmun. 1991 Aug;4(4):607-15
1723273
J Exp Med. 2008 Jun 9;205(6):1409-22
18474629
Clin Exp Immunol. 1999 Nov;118(2):290-7
10540193
J Immunol. 2003 Feb 1;170(3):1481-9
12538711
Nat Rev Immunol. 2009 Apr;9(4):246-58
19319143
Semin Liver Dis. 2009 Aug;29(3):262-72
19675999
Cell. 1991 Apr 19;65(2):319-31
1901765
Eur J Immunol. 1993 May;23(5):1105-11
7682958
J Immunol. 2005 May 1;174(9):5874-83
15845458
Hepatology. 2008 Aug;48(2):531-40
18563844
J Autoimmun. 2001 Nov;17(3):243-9
11712862
Hepatology. 2006 Feb;43(2 Suppl 1):S132-44
16447290
Hepatology. 2003 Nov;38(5):1250-7
14578864
Biol Pharm Bull. 2005 Dec;28(12):2240-3
16327157
J Autoimmun. 2010 Feb;34(1):38-44
19716269
Mol Immunol. 2004 Feb;40(14-15):1113-20
15036917
Autoimmunity. 2002 Dec;35(8):501-13
12765476
Proc Natl Acad Sci U S A. 1988 Nov;85(21):8256-60
3186722
J Clin Invest. 1991 Oct;88(4):1370-8
1717511
FASEB J. 1998 Oct;12(13):1255-65
9761770
Hepatology. 2007 Aug;46(2):472-84
17559153
Arch Biochem Biophys. 2000 Sep 15;381(2):191-204
11032406
Immunity. 1994 Jun;1(3):231-42
7889411
J Clin Invest. 1989 Mar;83(3):1066-72
2466049
Curr Opin Immunol. 2004 Dec;16(6):759-67
15511670
Nat Immunol. 2002 Jul;3(7):627-34
12055626
Gastroenterology. 2006 Mar;130(3):868-82
16530525
J Immunol. 1992 Aug 1;149(3):789-95
1321851
Trends Immunol. 2004 Feb;25(2):61-6
15102364
Cell. 1991 Apr 19;65(2):305-17
1901764
Drug Metab Dispos. 2008 Jul;36(7):1322-31
18420780
Hepatology. 1996 Dec;24(6):1416-21
8938173
Drug Metab Dispos. 2006 Jul;34(7):1167-74
16595712
J Clin Invest. 2004 Nov;114(9):1290-8
15520861